Rising Melanoma Cases Fueling Growth In Skin Cancer Diagnostics Market Driver: Leading Transformation in the Skin Cancer Diagnostics Market in 2025

What combination of drivers is leading to accelerated growth in the skin cancer diagnostics market?
The rise in melanoma cases is predicted to drive the expansion of the skin cancer diagnostics market in the future. Melanoma, a particular skin cancer type, occurs in melanin-producing cells, the pigment that colours skin, hair, and eyes. Skin cancer diagnostics play a pivotal role in detecting and categorising skin lesions, contributing to early detection, accurate diagnosis, and comprehensive treatment planning for skin cancer. For example, in 2023, as per a report from the American Cancer Society Inc., a voluntary health organisation in the US committed to eradicating cancer, the count of male melanoma patients in the United States escalated from 57,180 in 2022 to 58,120 in 2023. Additionally, as reported by the American Society of Clinical Oncology in March 2023, a professional body in the US comprising all oncology doctors, melanoma represents around 1% of all diagnosed skin cancers in the United States. However, it accounts for a significant portion of skin cancer deaths. It is projected that 7,990 people (5,420 males and 2,570 females) will succumb to melanoma in the United States in 2023. Hence, the escalating instances of melanoma are fuelling the expansion of the skin cancer diagnostics market.

Get Your Skin Cancer Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

What is the projected compound annual growth rate (CAGR) of the skin cancer diagnostics market from 2025 to 2034, and what factors influence it?
The market size of skin cancer diagnostics has seen robust growth in the past few years. A rise from $3.13 billion in 2024 to $3.39 billion in 2025 is projected, representing a compound annual growth rate (CAGR) of 8.4%. Factors that contributed to the growth in the historical period include an increased prevalence of skin cancer, a growing elderly population, and education and awareness programs. Additionally, government initiatives promoting early detection have also played a role.

It is anticipated that the market size for skin cancer diagnostics will exhibit robust growth in the forthcoming years, reaching a valuation of $4.69 billion in 2029, with a compound annual growth rate (CAGR) of 8.4%. The growth during the predicted period is attributed to increasing awareness about sun exposure, the implementation of personalized medicine strategies, advancements in telemedicine and remote monitoring technologies, and the worldwide growth of healthcare infrastructure. The forecast period will see significant trends such as the integration of digital health platforms, the development of innovative skin cancer treatments, the adoption of multi-disciplinary approaches, breakthroughs in dermatopathology, and heightened patient education and awareness.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11914&type=smp

What trends are poised to drive the future success of the skin cancer diagnostics market?
Major players in the skin cancer diagnostics industry are concentrating on introducing novel products like the PRAME protein to improve the identification and treatment tactics for melanoma and other types of skin cancers. PRAME, which stands for Preferentially Expressed Antigen in Melanoma, is a cancer/testis antigen that has shown promise in melanoma detection. For example, In October 2022, Roche, a healthcare firm operating globally from Switzerland, unveiled the PRAME (EPR20330) Antibody. This melanoma-associated antigen is geared towards identifying PRAME protein expression in tissue samples from individuals who might be suffering from melanoma. The antibody plays a crucial role in differentiating benign from malignant lesions. A sign of malignancy, the PRAME expression is essential for precise diagnosis and devising a treatment plan.

What are the major segments of the skin cancer diagnostics market and their role in driving growth?
The skin cancer diagnostics market covered in this report is segmented -

1) By Cancer Type: Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types
2) By Type: Diagnosis, Therapeutics
3) By Application: Hospital, Clinic, Laboratory, Other Applications

Subsegments:
1) By Basal Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests
2) By Squamous Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests
3) By Malignant Melanoma: Diagnostic Imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests
4) By Other Cancer Types: Non-Melanoma Skin Cancers, Dermatofibrosarcoma Protuberans, Merkel Cell Carcinoma

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11914

Which regions are key players in the growth of the skin cancer diagnostics market?
North America was the largest region in the skin cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the skin cancer diagnostics market?
Major companies operating in the skin cancer diagnostics market include Pfizer Inc., F. Hoffmann-La Roche Limited, Merck & Co., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi, Eli Lilly and Company, Canon Medical Systems Corporation, Amgen Inc., GE Healthcare, Daiichi Sankyo Company Limited., National Cancer Institute, Agilent Technologies Inc., bioMerieux SA, Teva Pharmaceutical Industries, Bruker Corp, Almirall, Genentech, Castle Biosciences, Sun Pharmaceutical Industries Limited., American Academy of Dermatology, Biolitec Ag, Alma Lasers, DermTech Inc., SkylineDx BV, DermLite LLC, AMLo Biosciences Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11914&type=smp

What Is Covered In The Skin Cancer Diagnostics Global Market Report?

• Market Size Forecast: Examine the skin cancer diagnostics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the skin cancer diagnostics market for a structured understanding.
• Key Players Overview: Analyze major players in the skin cancer diagnostics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the skin cancer diagnostics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the skin cancer diagnostics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the skin cancer diagnostics market.
• Industry Challenges: Identify potential risks and obstacles affecting the skin cancer diagnostics market.
• Competitive Landscape: Review strategic developments in the skin cancer diagnostics market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.